CUSIP 92663R105 · who reports it, how much, and how much it matters to them
15 of the 720 hedge fund managers we track reported shares of Viemed Healthcare, Inc. (Nasdaq: VMD) on Form 13F for 30 June 2026. Between them they reported USD 45m. The largest position belongs to Forager Capital Management, at USD 24m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Forager Capital Management1 fund on PPLI.com | USD 24m | 9.2% |
| 2 | Two Sigma Investments35 funds on PPLI.com | USD 5m | 0.0% |
| 3 | Renaissance Technologies13 funds on PPLI.com | USD 4.9m | 0.0% |
| 4 | Citadel Advisors32 funds on PPLI.com | USD 2.7m | 0.0% |
| 5 | Walleye Capital8 funds on PPLI.com | USD 2.1m | 0.0% |
| 6 | POINT72 Asset Management17 funds on PPLI.com | USD 1.8m | 0.0% |
| 7 | Mangrove Partners Im1 fund on PPLI.com | USD 868,000 | 0.1% |
| 8 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 694,000 | 0.0% |
| 9 | Verdad Advisers6 funds on PPLI.com | USD 603,000 | 0.6% |
| 10 | Millennium Management6 funds on PPLI.com | USD 592,000 | 0.0% |
| 11 | Magnetar Financial93 funds on PPLI.com | USD 471,000 | 0.0% |
| 12 | Engineers Gate Manager1 fund on PPLI.com | USD 418,000 | 0.0% |
| 13 | Squarepoint Ops7 funds on PPLI.com | USD 269,000 | 0.0% |
| 14 | Aristides Capital2 funds on PPLI.com | USD 194,000 | 0.0% |
| 15 | Summit Global Investments1 fund on PPLI.com | USD 412 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Forager Capital Management | USD 24m | 9.2% |
| 2 | Verdad Advisers | USD 603,000 | 0.6% |
| 3 | Mangrove Partners Im | USD 868,000 | 0.1% |
| 4 | Aristides Capital | USD 194,000 | 0.0% |
| 5 | Campbell & Company Investment Adviser | USD 694,000 | 0.0% |
| 6 | Summit Global Investments | USD 412 | 0.0% |
| 7 | Renaissance Technologies | USD 4.9m | 0.0% |
| 8 | Walleye Capital | USD 2.1m | 0.0% |
| 9 | Engineers Gate Manager | USD 418,000 | 0.0% |
| 10 | Two Sigma Investments | USD 5m | 0.0% |
Viemed Healthcare, Inc. trades under the symbol VMD on the Nasdaq. Its CUSIP, the code used on Form 13F, is 92663R105.
15 of the 720 hedge fund managers PPLI.com tracks reported Viemed Healthcare, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Forager Capital Management (USD 24m), Two Sigma Investments (USD 5m), Renaissance Technologies (USD 4.9m), Citadel Advisors (USD 2.7m) and Walleye Capital (USD 2.1m).
15 managers in our coverage reported it, and between them they run 231 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Forager Capital Management, where the position was 9.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Viemed Healthcare, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.